Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized Study of Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

NCT00239980 is registered in ClinicalTrials.gov with Ontario Clinical Oncology Group (OCOG) as lead sponsor.

NCT NCT00239980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00239980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized Study of Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)
Lead sponsor
Ontario Clinical Oncology Group (OCOG)
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2005
Completion date
January 31, 2010
Enrollment
77 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer